Compare BTTC & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTTC | CURX |
|---|---|---|
| Founded | 1990 | 2018 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4M | 14.5M |
| IPO Year | N/A | 2025 |
| Metric | BTTC | CURX |
|---|---|---|
| Price | $1.40 | $0.46 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 65.7K | ★ 193.5K |
| Earning Date | 01-01-0001 | 09-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.22 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.21 | $0.26 |
| 52 Week High | $11.22 | $9.18 |
| Indicator | BTTC | CURX |
|---|---|---|
| Relative Strength Index (RSI) | 50.54 | 51.22 |
| Support Level | $1.37 | $0.39 |
| Resistance Level | $1.80 | $0.53 |
| Average True Range (ATR) | 0.09 | 0.06 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 60.06 | 35.93 |
Black Titan Corp provides human resource and payroll consulting, software implementation, and training solutions using PeopleSoft platforms. The company's revenue is mainly derived from the provision of HCM solutions, followed by the provision of IT staff augmentation, outsourcing and consulting services.
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.